Corbion signs lactic acid agreement

24 Sep 2015

Corbion Purac and Malladi Specialties Limited (MSL) have signed an acquisition agreement to close on October 9th, 2015. MSL is an Indian manufacturer of lactic acid and lactic acid based derivatives such as calcium lactate, sodium lactate and buffered lactic acid and supplies the pharmaceutical, home and personal care, chemical and food industries in India. […]

Corbion signs lactic acid agreement

WFL_036Corbion Purac and Malladi Specialties Limited (MSL) have signed an acquisition agreement to close on October 9th, 2015.

MSL is an Indian manufacturer of lactic acid and lactic acid based derivatives such as calcium lactate, sodium lactate and buffered lactic acid and supplies the pharmaceutical, home and personal care, chemical and food industries in India.

The transaction includes the sales and delivery of lactic acid and lactic acid based derivatives in India. No production facilities will be acquired. Production will remain with Malladi Drugs and Pharmaceuticals Limited (MDPL), also part of the Malladi Group, which will produce derivatives on behalf of Corbion Purac. The transaction allows for a local production base through the partnership, while maintaining control on quality supplied to its customers, Corbion Purac said.

“For over 80 years Corbion Purac has been an established name and superior service provider in the food and pharmaceutical industry with lactic acid and its derivatives,” said Frank Goovaerts, Regional Vice President , Corbion Purac Asia Pacific. “MSL has a very strong customer base and distribution network in India. This acquisition will enable Corbion to grow its distribution network and customer service in India even further.”